Radiation therapy plays a critical role in the management of breast cancer and the sensitivity of the tumor cells to radiation is a critical determinant of the probability of local control and, ultimately, of cure. Tumors fail locally after radiation therapy due to alterations in the molecular pathways associated with the particular tumor. A variety of molecular factors are being used in clinical practice to predict the prognosis and response to radiation therapy of breast cancer patients. Unraveling the underlying mechanism controlling the development of resistance to radiation therapy can help delay onset or eliminate development of resistance and prolong treatment efficacy. HuR is an RNA binding protein, which functions to increase or decrease mRNA stability. Altering the subcellular distribution or expression of RNA binding proteins that alter mRNA stability has the potential to significantly alter levels of key growth promoting proteins. In this grant application we are proposing to test if cytoplasmic accumulation of the RNA binding protein-HuR in human breast cancer cells is a mechanism for the origin of radioresistant breast cancers. We believe that cytoplasmic HuR, through its interaction with stress activated signaling pathways and DNA repair proteins, functions to stabilize transcripts essential for cell survival and plays an important role in dictating radiation response. To address this, we propose the following specific aims:
Aim 1 : Investigate HuR expression levels in a panel of breast tumor and normal cell lines and study the effect of radiation on the subcellular distribution of HuR. Test the hypothesis that cytoplasmic HuR effects the MAPK and DNA repair proteins to modulate radiation resistance.
Aim 2 : Conduct in vitro and in vivo studies using HuR-targeted siRNA and determine the consequences of therapeutic intervention on modulation of radiation response and DNA repair.
Aim 3 : Generation of tissue arrays and immunohistochemical analysis on a cohort of human breast carcinomas to look for possible associations between radiation response and HuR expression and other clinicopathologic variables.

Public Health Relevance

We hypothesize that a better understanding of the interactions between HuR, MAPK and DNA repair pathways will identify proteins responsible for sensitivity and resistance to ionizing radiation. Understanding these mechanisms will ultimately permit the optimal integration of new inhibitors into breast cancer therapy and ultimately overcome resistance and failure to radiation therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM103639-02
Application #
8539819
Study Section
Special Emphasis Panel (ZRR1-RI-4)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
2
Fiscal Year
2013
Total Cost
$208,550
Indirect Cost
$67,639
Name
University of Oklahoma Health Sciences Center
Department
Type
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Boswell-Casteel, Rebba C; Johnson, Jennifer M; Duggan, Kelli D et al. (2014) FUN26 (function unknown now 26) protein from saccharomyces cerevisiae is a broad selectivity, high affinity, nucleoside and nucleobase transporter. J Biol Chem 289:24440-51
Aravindan, Natarajan; Aravindan, Sheeja; Pandian, Vijayabaskar et al. (2014) Acquired tumor cell radiation resistance at the treatment site is mediated through radiation-orchestrated intercellular communication. Int J Radiat Oncol Biol Phys 88:677-85
Bio, Moses; Rajaputra, Pallavi; Nkepang, Gregory et al. (2014) Far-red light activatable, multifunctional prodrug for fluorescence optical imaging and combinational treatment. J Med Chem 57:3401-9
Janakiram, Naveena B; Mohammed, Altaf; Brewer, Misty et al. (2014) Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila) 7:300-9
Babu, Anish; Wang, Qi; Muralidharan, Ranganayaki et al. (2014) Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells. Mol Pharm 11:2720-33
Xiong, Xunhao; Arvizo, Rochelle R; Saha, Sounik et al. (2014) Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles. Oncotarget 5:6453-65
Aravindan, S; Natarajan, M; Ramraj, S K et al. (2014) Abscopal effect of low-LET ýý-radiation mediated through Rel protein signal transduction in a mouse model of nontargeted radiation response. Cancer Gene Ther 21:54-9
VandenHeuvel, Katherine A; Carpentieri, David F; Chen, Jie et al. (2014) Ectomesenchymoma with embryonal rhabdomyosarcoma and ganglioneuroma, arising in association with benign triton tumor of the tongue. Pediatr Dev Pathol 17:226-30
Aravindan, Sheeja; Natarajan, Mohan; Herman, Terence S et al. (2013) Radiation-induced TNF* cross signaling-dependent nuclear import of NF*B favors metastasis in neuroblastoma. Clin Exp Metastasis 30:807-17
Chang, Theodore S; Lin, Hsueh-Kung; Rogers, Kyle A et al. (2013) Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung. Int J Clin Exp Pathol 6:2419-29

Showing the most recent 10 out of 11 publications